Ovarian Cancer Research Alliance (OCRA) has announced a collaboration with OPERATION WIPE OUT, an initiative that has demonstrated meaningful success reducing cervical cancer risk in Alabama through prevention-focused education and access to care. Drawing on this proven public-health framework, OCRA will adapt and expand the model nationwide—bringing practical, evidence-based cervical cancer prevention strategies to communities across the U.S.
“This collaboration is about scaling what we know works,” said Audra Moran, President and CEO of OCRA.
“OPERATION WIPE OUT has shown that focused prevention efforts can reduce cervical cancer risk in real communities. By bringing this model forward nationally—through coordinated policy leadership and public awareness—we have an opportunity to prevent disease, save lives, and move closer to eliminating cervical cancer as a public health threat.”
Learn more and explore downloadable prevention resources.
OCRA VP of Policy Featured in Citybiz on Launch of New Center for Public Policy
In a feature for Citybiz, OCRA’s Chad Ramsey shares the new Center for Public Policy’s role in expanding critical advocacy work and bringing more agency to the gynecologic cancer community, and discusses how patient, survivor, and caregiver experiences have helped shape OCRA’s advocacy priorities over the past decade.
OCRA-Funded Study Provides Clear New Evidence Fallopian Tube Removal Drastically Reduces Risk of Ovarian Cancer
Results from a study published in JAMA Network Open provide the clearest evidence to date that opportunistic salpingectomy—the removal of the fallopian tubes during another gynecologic surgery—can dramatically reduce the risk of ovarian cancer. The study was funded in part by OCRA, and co-led by members of OCRA’s Scientific Advisory Committee.
OCRA’s Advocate’s Corner
OCRA is entering 2026 with our largest Advocate Leader cohort in program history—and we are already seeing the results of their efforts. This week, Congress enacted a FY2026 funding package with major victories for the ovarian and gynecologic cancer community, achieving increases in research and education funding, strong support for prevention, and a Medicare coverage pathway for emerging early detection technologies. Learn more in OCRA’s Advocate’s Corner.
New Support Sessions
OCRA has expanded our free, online support offerings to help patients, caregivers, and families connect and find guidance. New sessions include cervical, vaginal and vulvar cancer groups, support for multiple diagnoses, caregiver grief support, Spanish-language sessions, and Narrative Medicine. Registration is required.
OCRA’s Staying Connected Support Series is generously sponsored by Genmab, Merck, PMV Pharma, and the Shirley Z. Johnson Trust.
In Loving Memory of Elle Simone Scott
We mourn the loss of late board member Elle Simone Scott—a culinary maverick, and a force of creativity, generosity, and purpose whose influence reached far beyond the kitchen. Diagnosed with ovarian cancer in 2016, Elle became a dedicated supporter of Ovarian Cancer Research Alliance and joined OCRA’s Board of Directors in 2019.
